VINGRAF 2MG CAPSULES
| Product Name | VINGRAF 2 |
| Active Ingredient | Tacrolimus |
| Strength | 2 mg |
| Dosage Form | Capsule |
| Therapeutic Class | Immunosuppressant |
| Pack Size | 10 x 6 Capsules per strip |
| Administration Route | Oral |
| Priscription Required | Yes |
VINGRAF 2MG CAPSULES
VINGRAF 2mg Capsules contain Tacrolimus, a potent immunosuppressant used to prevent organ transplant rejection and manage certain autoimmune disorders. Suppressing specific immune responses, it helps the body accept transplanted organs such as the kidney, liver, or heart, reducing the risk of rejection and complications. Proper dosing under medical supervision ensures maximum efficacy and safety.
This oral capsule is widely prescribed for patients who have undergone organ transplantation or those requiring immune modulation for autoimmune conditions. VINGRAF 2 mg works by inhibiting T-cell activation, which is a key factor in the bodyβs immune response. With careful monitoring, it helps maintain organ health, prolong graft survival, and support overall patient well-being.
VINGRAF 2 mgΒ Capsules combine convenience, effectiveness, and reliability in a simple oral dosage form. Regular use, as advised by a healthcare professional, ensures optimal immune suppression while minimizing potential side effects. Incorporating VINGRAF into a post-transplant care plan or autoimmune treatment regimen helps patients maintain a stable health condition and enhances long-term treatment outcomes.
Product Features
- Contains Tacrolimus 2mg for immunosuppressive therapy
- Prevents organ transplant rejection effectively
- Oral capsule for convenient administration
- Supports immune system modulation in autoimmune conditions
- Requires medical supervision for safe and effective use
How It Helps
- Prevents rejection of transplanted organs
- Suppresses overactive immune responses
- Supports long-term transplant health
- Helps manage certain autoimmune disorders

Reviews
There are no reviews yet.